Burcon NutraScience (NASDAQ:BRCN) reported quarterly losses of $(0.04) per share. This is a 100 percent decrease over losses of $(0.02) per share from the same period last year.
Why Is Genetic Testing Invitae Stock Trading Higher Today?
Friday, the FDA granted de novo approval for Invitae Corporation's (NYSE: